BIO-Europe Spring® 2017: Commercializing cell and gene therapies

April 4, 2017
New business models for clinical development and manufacturing require strategic partnerships among researchers, manufacturers and payers to fully realize the commercial opportunities.
Previous Video
BIO-Europe Spring® 2017: Stirring the entrepreneurial pot in Europe
BIO-Europe Spring® 2017: Stirring the entrepreneurial pot in Europe

Europe is home to many of the biggest pharma companies and the best academic biomedical researchers. But th...

Next Video
BIO-Europe Spring® 2017: Incorporating flexibility into your R&D strategy
BIO-Europe Spring® 2017: Incorporating flexibility into your R&D strategy

Strategic decisions made early in clinical development often have an impact on the downstream commercial po...